Cargando…

Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study

BACKGROUND: In many countries, HIV pre-exposure prophylaxis (PrEP) users are screened quarterly for STIs. We assessed the consequences of less frequent STI testing. We also assessed determinants of asymptomatic STI and potential for onward transmission. METHODS: Using data from the AMPrEP study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Jongen, Vita W., Zimmermann, Hanne M.L., Goedhart, Marit, Bogaards, Johannes A., Davidovich, Udi, Coyer, Liza, de Vries, Henry J.C., Prins, Maria, Hoornenborg, Elske, Schim van der Loeff, Maarten F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176338/
https://www.ncbi.nlm.nih.gov/pubmed/35584898
http://dx.doi.org/10.1136/sextrans-2022-055439
_version_ 1785040411916500992
author Jongen, Vita W.
Zimmermann, Hanne M.L.
Goedhart, Marit
Bogaards, Johannes A.
Davidovich, Udi
Coyer, Liza
de Vries, Henry J.C.
Prins, Maria
Hoornenborg, Elske
Schim van der Loeff, Maarten F.
author_facet Jongen, Vita W.
Zimmermann, Hanne M.L.
Goedhart, Marit
Bogaards, Johannes A.
Davidovich, Udi
Coyer, Liza
de Vries, Henry J.C.
Prins, Maria
Hoornenborg, Elske
Schim van der Loeff, Maarten F.
author_sort Jongen, Vita W.
collection PubMed
description BACKGROUND: In many countries, HIV pre-exposure prophylaxis (PrEP) users are screened quarterly for STIs. We assessed the consequences of less frequent STI testing. We also assessed determinants of asymptomatic STI and potential for onward transmission. METHODS: Using data from the AMPrEP study, we assessed the proportion of syphilis, and genital, anal, and pharyngeal chlamydia and gonorrhoea diagnoses which would have been delayed with biannual versus quarterly screening. We assessed the potential for onward transmission by examining reported condomless anal sex (CAS) in periods after to-be-omitted visits when screening biannually. We assessed determinants of incident asymptomatic STIs using Poisson regression and calculated individual risk scores on the basis of the coefficients from this model. RESULTS: We included 366 participants. Median follow-up was 47 months (IQR 43–50). 1,183STIs were diagnosed, of which 932(79%) asymptomatic. With biannual screening, 483 asymptomatic STIs (52%) diagnoses would have been delayed at 364 study visits. Of these visits, 129 (35%), 240 (66%) and 265 (73%) were followed by periods of CAS with steady, known casual or unknown casual partners, respectively. Older participants had a lower risk of asymptomatic STI (incidence rate ratio (IRR) 0.86/10-year increase, 95% CI 0.80 to 0.92), while CAS with known (IRR 1.36, 95% CI 1.10 to 1.68) and unknown (IRR 1.86, 95% CI 1.48 to 2.34) casual partners and chemsex (IRR 1.51, 95% CI 1.28 to 1.78) increased the risk. The individual risk scores had limited predictive value (sensitivity=0.70 (95% CI 0.66 to 0.74), specificity=0.50 (95% CI 0.48 to 0.51)). CONCLUSION: Reducing the STI screening frequency to biannually among PrEP users will likely result in delayed diagnoses, potentially driving onward transmission. Although determinants for asymptomatic STIs were identified, predictive power was low.
format Online
Article
Text
id pubmed-10176338
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-101763382023-05-13 Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study Jongen, Vita W. Zimmermann, Hanne M.L. Goedhart, Marit Bogaards, Johannes A. Davidovich, Udi Coyer, Liza de Vries, Henry J.C. Prins, Maria Hoornenborg, Elske Schim van der Loeff, Maarten F. Sex Transm Infect Original Research BACKGROUND: In many countries, HIV pre-exposure prophylaxis (PrEP) users are screened quarterly for STIs. We assessed the consequences of less frequent STI testing. We also assessed determinants of asymptomatic STI and potential for onward transmission. METHODS: Using data from the AMPrEP study, we assessed the proportion of syphilis, and genital, anal, and pharyngeal chlamydia and gonorrhoea diagnoses which would have been delayed with biannual versus quarterly screening. We assessed the potential for onward transmission by examining reported condomless anal sex (CAS) in periods after to-be-omitted visits when screening biannually. We assessed determinants of incident asymptomatic STIs using Poisson regression and calculated individual risk scores on the basis of the coefficients from this model. RESULTS: We included 366 participants. Median follow-up was 47 months (IQR 43–50). 1,183STIs were diagnosed, of which 932(79%) asymptomatic. With biannual screening, 483 asymptomatic STIs (52%) diagnoses would have been delayed at 364 study visits. Of these visits, 129 (35%), 240 (66%) and 265 (73%) were followed by periods of CAS with steady, known casual or unknown casual partners, respectively. Older participants had a lower risk of asymptomatic STI (incidence rate ratio (IRR) 0.86/10-year increase, 95% CI 0.80 to 0.92), while CAS with known (IRR 1.36, 95% CI 1.10 to 1.68) and unknown (IRR 1.86, 95% CI 1.48 to 2.34) casual partners and chemsex (IRR 1.51, 95% CI 1.28 to 1.78) increased the risk. The individual risk scores had limited predictive value (sensitivity=0.70 (95% CI 0.66 to 0.74), specificity=0.50 (95% CI 0.48 to 0.51)). CONCLUSION: Reducing the STI screening frequency to biannually among PrEP users will likely result in delayed diagnoses, potentially driving onward transmission. Although determinants for asymptomatic STIs were identified, predictive power was low. BMJ Publishing Group 2023-05 2022-05-18 /pmc/articles/PMC10176338/ /pubmed/35584898 http://dx.doi.org/10.1136/sextrans-2022-055439 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Jongen, Vita W.
Zimmermann, Hanne M.L.
Goedhart, Marit
Bogaards, Johannes A.
Davidovich, Udi
Coyer, Liza
de Vries, Henry J.C.
Prins, Maria
Hoornenborg, Elske
Schim van der Loeff, Maarten F.
Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study
title Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study
title_full Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study
title_fullStr Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study
title_full_unstemmed Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study
title_short Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study
title_sort can we screen less frequently for sti among prep users? assessing the effect of biannual sti screening on timing of diagnosis and transmission risk in the amprep study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176338/
https://www.ncbi.nlm.nih.gov/pubmed/35584898
http://dx.doi.org/10.1136/sextrans-2022-055439
work_keys_str_mv AT jongenvitaw canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT zimmermannhanneml canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT goedhartmarit canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT bogaardsjohannesa canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT davidovichudi canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT coyerliza canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT devrieshenryjc canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT prinsmaria canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT hoornenborgelske canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy
AT schimvanderloeffmaartenf canwescreenlessfrequentlyforstiamongprepusersassessingtheeffectofbiannualstiscreeningontimingofdiagnosisandtransmissionriskintheamprepstudy